|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|Ticker||Company||Price||Change||Chg %||Mkt Cap|
You can purchase shares of Akebia Therapeutics (NASDAQ: AKBA) through any online brokerage.
There are no as such competitors for Akebia Therapeutics.
The latest price target for Akebia Therapeutics (NASDAQ: AKBA) was reported by Cantor Fitzgerald on 2021-03-08. The analyst firm set a price target for 8.00 expecting AKBA to rise to within 12 months (a possible 156.82% upside). 13 analyst firms have reported ratings in the last year.
The stock price for Akebia Therapeutics (NASDAQ: AKBA) is $3.115 last updated Today at 8:00:03 PM.
There are no upcoming dividends for Akebia Therapeutics.
There is no upcoming split for Akebia Therapeutics.